Cyclerion Therapeutics Inc banner

Cyclerion Therapeutics Inc
NASDAQ:CYCN

Watchlist Manager
Cyclerion Therapeutics Inc Logo
Cyclerion Therapeutics Inc
NASDAQ:CYCN
Watchlist
Price: 1.32 USD
Market Cap: $5.2m

Cash Flow Statement

Cash Flow Statement
Cyclerion Therapeutics Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Operating Cash Flow
Net Income
(108)
(112)
(115)
(153)
(130)
(128)
(123)
(106)
(93)
(85)
(78)
(71)
(68)
(60)
(52)
(51)
(48)
(48)
(44)
(38)
(29)
(11)
(5)
0
3
(5)
(3)
(3)
(2)
(2)
Depreciation & Amortization
1
1
2
2
2
3
3
3
3
2
2
2
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Stock-Based Compensation
0
8
12
13
20
19
20
20
17
16
15
13
12
10
10
9
8
8
6
5
3
1
1
0
0
1
1
1
0
0
Other Non-Cash Items
10
11
12
16
17
19
20
18
16
13
11
11
16
17
13
13
5
4
6
5
4
(10)
(11)
(12)
(12)
0
0
0
0
0
Change in Working Capital
1
(1)
4
2
6
3
(2)
(12)
(15)
(11)
(8)
0
1
(0)
1
3
3
1
(3)
(1)
(4)
(6)
(5)
(5)
(3)
(1)
(2)
(1)
(1)
0
Cash from Operating Activities
(95)
N/A
(100)
-5%
(98)
+3%
(132)
-35%
(105)
+21%
(103)
+1%
(102)
+1%
(97)
+5%
(89)
+8%
(81)
+10%
(72)
+10%
(58)
+20%
(49)
+15%
(42)
+15%
(37)
+13%
(35)
+4%
(40)
-15%
(42)
-5%
(41)
+4%
(34)
+16%
(30)
+13%
(27)
+10%
(21)
+21%
(17)
+20%
(11)
+32%
(6)
+46%
(4)
+31%
(3)
+21%
(3)
+18%
(1)
+51%
Investing Cash Flow
Capital Expenditures
(2)
(2)
(3)
(5)
(9)
(9)
(7)
(6)
(2)
(2)
(2)
(0)
(0)
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Items
0
0
0
0
0
0
0
0
0
0
2
3
3
3
1
0
0
0
0
0
0
10
10
0
10
0
0
0
0
0
Cash from Investing Activities
(2)
N/A
(2)
-23%
(3)
-68%
(5)
-53%
(9)
-72%
(8)
+7%
(7)
+20%
(6)
+7%
(2)
+67%
(2)
+27%
0
N/A
3
+14 100%
3
+2%
3
N/A
1
-50%
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
10
N/A
10
+0%
0
N/A
10
N/A
0
-100%
0
N/A
0
N/A
0
N/A
0
N/A
Financing Cash Flow
Net Issuance of Common Stock
0
0
0
0
175
175
176
176
1
25
25
25
55
31
31
31
0
0
0
0
5
5
5
0
0
0
0
1
1
3
Net Issuance of Debt
0
0
0
0
0
0
0
0
4
4
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other
97
102
101
137
87
61
36
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
Cash from Financing Activities
97
N/A
102
+5%
101
-1%
137
+36%
262
+92%
236
-10%
212
-11%
175
-17%
4
-98%
28
+573%
28
+0%
28
+0%
55
+96%
31
-44%
31
0%
31
0%
0
-100%
0
-27%
0
-73%
0
N/A
5
N/A
5
N/A
5
0%
0
N/A
0
N/A
0
N/A
0
N/A
1
N/A
1
-9%
3
+147%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
0
0
0
0
0
0
(0)
0
0
0
0
0
0
0
0
(0)
(0)
0
0
Net Change in Cash
0
N/A
0
N/A
0
N/A
0
N/A
149
+1 487 500%
125
-16%
103
-18%
72
-30%
(87)
N/A
(54)
+38%
(44)
+18%
(27)
+40%
9
N/A
(8)
N/A
(4)
+48%
(4)
+3%
(40)
-868%
(42)
-5%
(41)
+4%
(34)
+16%
(25)
+27%
(11)
+54%
(6)
+49%
(1)
+75%
(1)
+29%
(6)
-497%
(4)
+30%
(2)
+53%
(2)
+23%
2
N/A
Free Cash Flow
Free Cash Flow
(97)
N/A
(102)
-5%
(101)
+1%
(137)
-36%
(114)
+17%
(112)
+2%
(109)
+2%
(104)
+5%
(92)
+12%
(82)
+10%
(74)
+10%
(58)
+22%
(49)
+15%
(42)
+15%
(37)
+13%
(35)
+4%
(40)
-15%
(42)
-5%
(41)
+4%
(34)
+16%
(30)
+13%
(27)
+10%
(21)
+21%
(17)
+20%
(11)
+32%
(6)
+46%
(4)
+31%
(3)
+21%
(3)
+18%
(1)
+51%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett